Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 1
2008 1
2010 1
2011 1
2016 1
2017 1
2018 1
2019 3
2020 3
2021 2
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC.
Socinski MA, Jotte RM, Cappuzzo F, Orlandi F, Stroyakovskiy D, Nogami N, Rodríguez-Abreu D, Moro-Sibilot D, Thomas CA, Barlesi F, Finley G, Kelsch C, Lee A, Coleman S, Deng Y, Shen Y, Kowanetz M, Lopez-Chavez A, Sandler A, Reck M; IMpower150 Study Group. Socinski MA, et al. N Engl J Med. 2018 Jun 14;378(24):2288-2301. doi: 10.1056/NEJMoa1716948. Epub 2018 Jun 4. N Engl J Med. 2018. PMID: 29863955 Free article. Clinical Trial.
Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung Cancer.
Peters S, Camidge DR, Shaw AT, Gadgeel S, Ahn JS, Kim DW, Ou SI, Pérol M, Dziadziuszko R, Rosell R, Zeaiter A, Mitry E, Golding S, Balas B, Noe J, Morcos PN, Mok T; ALEX Trial Investigators. Peters S, et al. N Engl J Med. 2017 Aug 31;377(9):829-838. doi: 10.1056/NEJMoa1704795. Epub 2017 Jun 6. N Engl J Med. 2017. PMID: 28586279 Free article. Clinical Trial.
Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC): neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI).
Mandaliya H, Jones M, Oldmeadow C, Nordman II. Mandaliya H, et al. Among authors: nordman ii. Transl Lung Cancer Res. 2019 Dec;8(6):886-894. doi: 10.21037/tlcr.2019.11.16. Transl Lung Cancer Res. 2019. PMID: 32010567 Free PMC article.
Women's cardiovascular health - the cardio-oncologic jigsaw.
Ray M, Butel-Simoes LE, Lombard JM, Nordman IIC, Van der Westhuizen A, Collins NJ, Ngo DTM, Sverdlov AL. Ray M, et al. Among authors: nordman iic. Climacteric. 2024 Feb;27(1):60-67. doi: 10.1080/13697137.2023.2286382. Epub 2024 Jan 15. Climacteric. 2024. PMID: 38073542 Review.
Patterns of care for stage III non-small cell lung cancer in Australia.
Parente P, Chan BA, Hughes BGM, Jasas K, Joshi R, Kao S, Hegi-Johnson F, Hui R, McLaughlin-Barrett S, Nordman I, Stone E. Parente P, et al. Among authors: nordman i. Asia Pac J Clin Oncol. 2019 Jun;15(3):93-100. doi: 10.1111/ajco.13140. Epub 2019 Mar 14. Asia Pac J Clin Oncol. 2019. PMID: 30868747 Review.
Strongyloides-An uncommon cause of eosinophilia whilst on durvalumab.
Quah GT, Blanchard G, Miller N, Wilson P, Nordman I. Quah GT, et al. Among authors: nordman i. Cancer Rep (Hoboken). 2022 Oct;5(10):e1682. doi: 10.1002/cnr2.1682. Epub 2022 Jul 18. Cancer Rep (Hoboken). 2022. PMID: 35852050 Free PMC article.
20 results